Close Menu

NEW YORK – Relatively few tests marketed for use at home have been cleared by the US Food and Drug Administration, but test developers in 2019 continued to innovate, collaborate, and raise funds in anticipation of future successes.

According to diagnostic test developers, more at-home tests, sometimes referred to as self-tests, need to demonstrate affordability and have levels of performance as high as, or better than, laboratory tests to achieve regulatory clearances and market acceptance.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.